Stephen Hauser
Internal Medicine · San Francisco, CANPI 1700996931
Payments from drug & device makers
Across 85 payments — averaging $850.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- F. Hoffmann-la Roche AG$43K
- Novartis Pharma AG$11K
- Genentech, Inc.$9K
- Modernatx, Inc.$4K
- Gilead$3K
- BD$2K
- plus $485 from 5 others
Across 102 payments — averaging $1322.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$126K
- Novartis Pharma AG$6K
- Novartis$2K
What the payments were for
- Consulting fees$9,28913%
- Speaking & faculty fees$33,17046%
- Travel & lodging$29,02140%
- Food & beverage$8511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| F. Hoffmann-la Roche AG | 53 | $42,994 |
| Novartis Pharma AG | 9 | $11,205 |
| Genentech, Inc. | 10 | $9,146 |
| Modernatx, Inc. | 2 | $4,000 |
| Gilead | 1 | $3,000 |
| BD | 1 | $1,500 |
| Genentech USA, Inc. | 4 | $193 |
| Biomarin Pharmaceutical Inc. | 1 | $81 |
| Roche Products Limited | 2 | $77 |
| Leica Microsystems Inc. | 1 | $71 |
| Novartis | 1 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$72,330 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dalfampridine ErDalfampridine | 17 | $2,060 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in San Francisco
- Rahul AggarwalSan Francisco$24M
- Thomas MartinSan Francisco$13.7M
- Peter HuntSan Francisco$9.8M
- Diane HavlirSan Francisco$8.4M
- Sandy WongSan Francisco$6.6M
- Nina ShahSan Francisco$5.4M
- Katy TsaiSan Francisco$3.8M
- Riley BoveSan Francisco$3.6M
- Jacob LalezariSan Francisco$3.3M
- Flavio VincentiSan Francisco$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.